Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659003 · ClinicalTrials.gov registry record
Developing and Testing a Social Network Data Capture Tool to Improve Partner Services: a Preliminary Pilot Implementation
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 23
- Enrollment target
NCT06659003: Completed study, sponsored by Northwestern University.
NCT06659003 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06659003 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This study conducted a preliminary pilot implementation which integrated our existing social network software - Network Canvas - into Chicago Partner Services in order to understand the feasibility and acceptability of this integration, and to gather preliminary evidence of potential efficacy in improving Partner Services metrics. All of this work will be conducted through an Active Implementation Framework in which we utilized a staged- approach and strong engagement with local (e.g., Chicago Department of Public Health and Howard Brown Health) and national stakeholders to explore, install, and implement a software pilot into Partner Services.
Primary Outcome
We will assess the feasibility of our initial implementation of Network Canvas. We define feasibility here as satisfaction with and usability of all major areas of our initial reconfiguration of Network Canvas for CDPH. For example, we will measure the satisfaction with and usability of our touchscreen interfaces, our procedures for deployment and data management, and important logistical supports such as our training materials, the support provided by our team, and our procedures for evaluation
Interventions
- OTHER Pilot Implementation of Network Canvas into HBH Partner Services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2024-05-31 |
What the finished NCT06659003 record still lists
NCT06659003 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pilot Implementation of Network Canvas into HBH Partner Services is the first listed.
NCT06659003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06659003 about?
NCT06659003 is a clinical study titled "Developing and Testing a Social Network Data Capture Tool to Improve Partner Services: a Preliminary Pilot Implementation". This study conducted a preliminary pilot implementation which integrated our existing social network software - Network Canvas - into Chicago Partner Services in order to understand the feasibility and acceptability of this integration, and to gather preliminary evidence of potential efficacy in imp...
What is the current status of trial NCT06659003?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2023-07-01. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT06659003?
The interventions under investigation include: Pilot Implementation of Network Canvas into HBH Partner Services (OTHER).
Who is sponsoring clinical trial NCT06659003?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI